# Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy

> **NCT06051240** · PHASE2 · RECRUITING · sponsor: **Region Stockholm** · enrollment: 84 (estimated)

## Conditions studied

- Cognitive Impairment
- Cognitive Decline
- Radiotherapy Side Effect
- Radiotherapy; Complications
- Brain Tumor
- Memory Impairment
- Late Effect of Radiation

## Interventions

- **DRUG:** Lithium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06051240
- **Lead sponsor:** Region Stockholm
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-16
- **Primary completion:** 2030-08-31
- **Final completion:** 2033-08-31
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2024-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06051240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06051240, "Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06051240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*